Patient-Reported Outcomes in Virologically Suppressed, HIV-1–Infected Subjects After Switching to a Simplified, Single-Tablet Regimen of Efavirenz, Emtricitabine, and Tenofovir DF-Reference-Cited by-同舟云学术

Patient-Reported Outcomes in Virologically Suppressed, HIV-1–Infected Subjects After Switching to a Simplified, Single-Tablet Regimen of Efavirenz, Emtricitabine, and Tenofovir DF

Published:2010-02 Issue:2 Volume:24 Page:87-96
ISSN:1087-2914
Container-title:AIDS Patient Care and STDs
language:en
Short-container-title:AIDS Patient Care and STDs

Author:

Hodder Sally L.¹,Mounzer Karam²³,DeJesus Edwin⁴,Ebrahimi Ramin⁵,Grimm Kristy⁶,Esker Stephen⁶,Ecker Janet⁵,Farajallah Awny⁶,Flaherty John F.⁵

Affiliation:

1. University of Medicine and Dentistry of New Jersey, Newark, New Jersey.

2. Philadelphia FIGHT, Philadelphia, Pennsylvania.

3. University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania.

4. Orlando Immunology Center, Orlando, Florida.

5. Gilead Sciences, Inc., Foster City, California.

6. Bristol-Myers Squibb, Princeton, New Jersey.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/apc.2009.0259

Reference20 articles.

1. Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients

2. Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

3. Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients

4. Bioequivalence of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen

5. Simplification Therapy with Once‐Daily Emtricitabine, Didanosine, and Efavirenz in HIV‐1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence of a Pediatric Fixed‐Dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Compared With Coadministration of the Separate Agents in Healthy Adults: An Open‐Label, Randomized, Replicate Crossover Study;Clinical Pharmacology in Drug Development;2023-06-19

2. The transformation of HIV therapy: One pill once a day;Antiviral Therapy;2022-04

3. One Pill, Once a Day: Simplified Treatment Regimens and Retention in HIV Care;American Journal of Epidemiology;2022-01-27

4. Patient-reported outcomes among people living with HIV on single- versus multi-tablet regimens: Data from a real-life setting;PLOS ONE;2022-01-13

5. Redefining therapeutic success in HIV patients: an expert view;Journal of Antimicrobial Chemotherapy;2021-06-02